FindTrial
Sign In

IIV

BIOLOGICAL4 trials

Sponsors

Marshfield Clinic Research Foundation, MedImmune LLC, Duke University

Conditions

Febrile SeizureFeverFever After VaccinationImmune Response to Influenza VaccineInfluenza A Virus InfectionInfluenza B Virus InfectionRespiratory Syncytial VirusRespiratory Syncytial Virus (RSV)

Phase 1

A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults
CompletedNCT02289820
MedImmune LLCRespiratory Syncytial Virus (RSV)
Start: 2015-01-05End: 2016-02-24Updated: 2018-03-15

Phase 2

A Study to Evaluate the Efficacy of MEDI7510 in Older Adults
TerminatedNCT02508194
MedImmune LLCRespiratory Syncytial Virus
Start: 2015-09-29End: 2016-11-07Updated: 2017-12-26

Phase 4

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents
CompletedNCT02250274
Marshfield Clinic Research FoundationImmune Response to Influenza Vaccine, Influenza A Virus Infection, Influenza B Virus Infection
Start: 2014-09-30End: 2015-04-30Updated: 2018-04-26
Fever After Simultaneous Versus Sequential Vaccination in Young Children
CompletedNCT03165981
Duke UniversityFebrile Seizure, Fever, Fever After Vaccination
Start: 2017-08-25End: 2018-01-15Updated: 2024-11-18

Related Papers

Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation.
2019-11-2121 citations
An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults
The Journal of Infectious Diseases2017-09-18128 citations
Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
Clinical and Vaccine Immunology2017-07-0634 citations